Skelemus Warnings

Eperisone Hydrochloride Sustained Release capsules 150mg is contraindicated in patients with hypersensitivity to any of the ingredients. It is not advocated in small children below 18 months of age and during lactation. Eperisone Hydrochloride Sustained Release capsules 150mg should be administered with caution in acidpeptic disease, impaired renal or liver functions, blood dyscrasias, and hypersensitivity to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). Patients taking Eperisone Hydrochloride Sustained Release capsules 150mg should be cautioned against engaging in potentially hazardous activities requiring alertness eg, operating machinery or driving a car. Avoid alcoholic beverages whilst taking Eperisone Hydrochloride Sustained Release capsules 150mg.
Methocarbamol, aspirin, methotrexate, digoxin, cyclosporin, angiotensin converting enzyme (ACE) inhibitors, diuretics, lithium and warfarin are to be coadministered with due precaution with Eperisone Hydrochloride Sustained Release capsules 150mg.